Abuse of dominance under competition law requires proof of competitive harm, objective justification, and fair procedure.

Abuse of dominance under the Competition Act requires a showing of non-neutral conduct, lack of objective justification, and competitive harm. The target-discount scheme, functional rebate, no-Chinese condition, TMLA arrangement, LTTSA and alleged NGA/NGC tying were found not to be abusive because the evidence showed uniform commercial terms, quality-linked justification, no downstream foreclosure, and no coercion. An effects-based inquiry was treated as mandatory, but no appreciable adverse effect on competition was established on the record. Denial of cross-examination was also held to be a serious natural justice defect because the adverse findings depended materially on untested witness statements.

---

---

Issues: (i) Whether the target-discount scheme amounted to discriminatory or exclusionary pricing under Section 4(2)(a) and Section 4(2)(b) of the Competition Act, 2002; (ii) Whether the functional-discount and no-Chinese scheme, including the later TMLA arrangement, imposed unfair or discriminatory conditions under Section 4(2)(a) and Section 4(2)(b) of the Competition Act, 2002; (iii) Whether the LTTSA with Schott Kaisha produced a margin squeeze proscribed by Section 4(2)(e) of the Competition Act, 2002; (iv) Whether NGA and NGC tubes were tied or bundled in breach of Section 4(2)(d) of the Competition Act, 2002; (v) Whether an effects-based harm analysis is an essential component of an inquiry under Section 4 of the Competition Act, 2002; and (vi) Whether the investigation and the Commission's order were vitiated by denial of cross-examination and allied breaches of natural justice.

Issue (i): Whether the target-discount scheme amounted to discriminatory or exclusionary pricing under Section 4(2)(a) and Section 4(2)(b) of the Competition Act, 2002.

Analysis: The rebate ladder applied uniformly to all purchasers and turned only on aggregate volume. Differential results flowed from different quantities purchased, not from unequal treatment of equivalent transactions. The scheme was supported by commercial justification linked to furnace utilisation and scale efficiencies, and the record did not show foreclosure, restricted output, or downstream price distortion.

Conclusion: The target-discount scheme was not abusive and the issue was answered against the appellants.

Issue (ii): Whether the functional-discount and no-Chinese scheme, including the later TMLA arrangement, imposed unfair or discriminatory conditions under Section 4(2)(a) and Section 4(2)(b) of the Competition Act, 2002.

Analysis: The functional rebate was available on equal terms to any converter willing to undertake the same traceability and branding obligations. The no-Chinese condition was found to be connected with quality and patient-safety concerns and was later withdrawn. The evidence did not show differential pricing for equivalent transactions or market restriction attributable to these arrangements.

Conclusion: The functional rebate and the TMLA-based arrangement were not unfair or discriminatory and the issue was answered against the appellants.

Issue (iii): Whether the LTTSA with Schott Kaisha produced a margin squeeze proscribed by Section 4(2)(e) of the Competition Act, 2002.

Analysis: Margin squeeze requires downstream participation by the dominant firm, an insufficient spread for an equally efficient rival, and competitive harm. Schott India did not operate downstream, the evidence showed independent converters remained profitable, and there was no demonstrated foreclosure or exit from the market. The LTTSA was treated as a commercially rational bulk-purchase commitment.

Conclusion: No margin squeeze was proved and the issue was answered against the appellants.

Issue (iv): Whether NGA and NGC tubes were tied or bundled in breach of Section 4(2)(d) of the Competition Act, 2002.

Analysis: The two grades were treated as alternative specifications drawn from a common production process rather than truly independent products. Even assuming distinct products, the record did not establish coercion, compulsory purchase of both grades, or foreclosure of competition in a tied-product market. The aggregation of purchases for rebate calculation was treated as a multi-product volume discount and was also commercially justified.

Conclusion: No tying or bundling was established and the issue was answered against the appellants.

Issue (v): Whether an effects-based harm analysis is an essential component of an inquiry under Section 4 of the Competition Act, 2002.

Analysis: Abuse of dominance requires not only classification of conduct under the statutory clauses but also assessment of competitive harm. The statutory scheme, its preambular purpose, and the structure of the Act were read as requiring a concrete effects inquiry. On the record, the alleged conduct did not produce appreciable adverse effect on competition, as output grew, prices remained stable, and no foreclosure was shown.

Conclusion: An effects-based analysis is mandatory and, on the facts, no appreciable adverse effect on competition was established; the issue was answered in favour of the appellants on the legal question but against them on the factual application.

Issue (vi): Whether the investigation and the Commission's order were vitiated by denial of cross-examination and allied breaches of natural justice.

Analysis: The adverse findings rested substantially on untested witness statements. Cross-examination was sought but refused, and that refusal was held to be a serious procedural defect under the statutory and natural justice framework. The denial materially undermined the evidentiary basis of the Commission's conclusions.

Conclusion: The proceedings were vitiated by denial of cross-examination and the issue was answered in favour of the appellants.

Final Conclusion: The appeals failed because the impugned competition findings were not sustainable on merits and were also undermined by a serious procedural infirmity. The order of the appellate tribunal was affirmed and the challenge to the Commission's directions did not succeed.

Ratio Decidendi: In an abuse-of-dominance inquiry, a dominant undertaking's conduct is actionable only when the impugned practice is shown to be non-neutral, lacking objective justification, and capable of causing competitive harm, and findings resting substantially on untested adverse testimony are vulnerable where cross-examination is wrongly denied.

---